BioSpace News Archive

Pharm Country

IO Biotech to Present at the 2023 Jefferies Healthcare Conference

IO Biotech announced that Mai-Britt Zocca, Ph.D., the company’s President and CEO, and Amy Sullivan, the company’s CFO, will be presenting and participating in one-on-one investor meetings at the Jefferies Healthcare Conference to be held June 7-9 in New York City.

May 30, 2023
·
2 min read
Biotech Bay

Olema Oncology to Present at the 2023 Jefferies Healthcare Conference

Olema Pharmaceuticals, Inc. (“Olema”, “Olema Oncology”, Nasdaq: OLMA) today announced that Sean P. Bohen, M.D., Ph.D., President and Chief Executive Officer, will participate in a Fireside Chat at the 2023 Jefferies Healthcare Conference in New York on Wednesday, June 7, 2023, at 3:00 p.m. ET.

May 30, 2023
·
1 min read
Genetown

Boston Scientific Announces Conversion Date of Series A Mandatory Convertible Preferred Stock

Boston Scientific Corporation announced that its Series A 5.50% Mandatory Convertible Preferred Stock will automatically convert into shares of the company’s common stock on June 1, 2023.

May 30, 2023
·
1 min read
Genetown

ABCAM PLC: Statement on calling an Extraordinary General Meeting

Abcam plc, a global leader in the supply of life science research tools, notes that it has received a notice from Dr. Jonathan Milner seeking to require the Board of Directors to convene an Extraordinary General Meeting.

May 30, 2023
·
4 min read
Pharm Country

Carisma Therapeutics to Present at Upcoming Healthcare Industry Conferences in June 2023

Carisma Therapeutics Inc. (Nasdaq: CARM) (“Carisma” or the “Company”), a clinical stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced that the Company will present at several healthcare industry conferences in June 2023.

May 30, 2023
·
4 min read
BioForest

CTI BioPharma Announces Cancellation of its 2023 Annual Meeting of Stockholders

CTI BioPharma Corp. announced that it has cancelled the 2023 Annual Meeting of Stockholders which was scheduled for June 21, 2023, and has withdrawn the proposals to have been submitted to stockholders at the Annual Meeting.

May 30, 2023
·
6 min read
Epithelial Cell Culture Media Market Growing at a CAGR of 11.4% and it is expected to reach US$ 303,040.33 thousand by 2028, Says The Insight Partners

According to our new research study on “Epithelial Cell Culture Media Market Forecast to 2028 – COVID-19 Impact and Global Analysis

May 30, 2023
·
5 min read
Multiple Sclerosis Therapeutics Market Projected to reach US$ 39,223.59 million by 2027 COVID-19 Impact and Global Analysis

According to our new market research study on “Multiple Sclerosis Therapeutics Market to Forecast 2027

May 30, 2023
·
4 min read
Drug Development

AMGEN PRESENTS NEW RESEARCH ON OTEZLA® (APREMILAST) IN PSORIATIC ARTHRITIS AT EULAR 2023

Amgen (NASDAQ:AMGN) today announced new research examining the use of Otezla® (apremilast) in psoriatic arthritis, including the Phase 4 MOSAIC study and an exploratory analysis of cardiometabolic risk factors, which are commonly elevated in patients with psoriatic disease.

May 30, 2023
·
18 min read
Business

SQI Diagnostics Reports Second Quarter 2023 Results

SQI Diagnostics Inc. (“SQI” or the “Company”) (TSXV: SQD) (OTCQB: SQIDF), a leader in the science of lung health that develops and manufactures respiratory health and precision medicine tests today reported its financial and operational results for the second quarter ended March 31, 2022.

May 30, 2023
·
7 min read